Lupin Ltd: FDA Issues Positive Inspection Report for Somerset Facility

✅

Ltd has received an Establishment Inspection Report (EIR) from the U.S. FDA for its Somerset, New Jersey facility, following a successful inspection from January 27-31, 2025. This confirms compliance with FDA regulations and good manufacturing practices, strengthening Lupin's position in the U.S. market.